SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,737,843 | +96.1% | 181,625 | +348.1% | 0.47% | +80.2% |
| Q2 2023 | $1,905,768 | +72.6% | 40,531 | +54.0% | 0.26% | +74.7% |
| Q1 2023 | $1,104,387 | +195.1% | 26,320 | +168.3% | 0.15% | +145.9% |
| Q4 2022 | $374,192 | -1.0% | 9,811 | +1.6% | 0.06% | +7.0% |
| Q3 2022 | $378,000 | -86.3% | 9,659 | -88.7% | 0.06% | -76.5% |
| Q2 2022 | $2,751,000 | -27.5% | 85,161 | -25.7% | 0.24% | -25.7% |
| Q1 2022 | $3,794,000 | +14.8% | 114,616 | +47.5% | 0.33% | +29.8% |
| Q4 2021 | $3,305,000 | -16.1% | 77,683 | -12.6% | 0.25% | -11.0% |
| Q3 2021 | $3,939,000 | -24.8% | 88,900 | -3.6% | 0.28% | -18.2% |
| Q2 2021 | $5,238,000 | +53.8% | 92,209 | +102.6% | 0.35% | +41.2% |
| Q1 2021 | $3,406,000 | -45.9% | 45,503 | -37.5% | 0.24% | -42.5% |
| Q4 2020 | $6,298,000 | +31.2% | 72,800 | -7.3% | 0.43% | +34.4% |
| Q3 2020 | $4,802,000 | +6.3% | 78,570 | -27.7% | 0.32% | +3.3% |
| Q2 2020 | $4,519,000 | – | 108,675 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |